News Releases

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
5/10/2018
4:05 PM ET
Earnings Release

Diffusion Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update

5/10/2018

Patient screening and enrollment are underway in Phase 3 inoperable GBM brain cancer trialKey U.S. Patent IssuedClinical trial preparations are ongoing for Phase 2 trial with TSC in strokeCHARLOTTESVI...

 Continue Reading
4/3/2018
7:30 AM ET
Earnings Release

Diffusion Pharmaceuticals Reports 2017 Financial Results and Provides Business Update

4/3/2018

Patient Enrollment in Phase 3 Inoperable GBM Brain Cancer Trial Underway Raised $12 Million in Underwritten Public Offering Preparing to Commence Clinical Trial with TSC in StrokeExpanded Intellectual...

 Continue Reading
2/6/2018
4:00 PM ET
Press Release

Diffusion Pharmaceuticals to Present at the 2018 BIO CEO & Investor Conference

2/6/2018

CHARLOTTESVILLE, Va., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc.(NASDAQ:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the li...

 Continue Reading
2/1/2018
8:15 AM ET
Press Release

Diffusion Pharmaceuticals Announces Allowances of Two U.S. Patent Applications

2/1/2018

CHARLOTTESVILLE, Va., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc.(NASDAQ:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the li...

 Continue Reading
1/29/2018
4:00 PM ET
Press Release

Diffusion Pharmaceuticals Announces First Patient Dosed in Phase 3 Trial with TSC in Inoperable Glioblastoma Multiforme

1/29/2018

CHARLOTTESVILLE, Va., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc.(NASDAQ:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the li...

 Continue Reading
1/24/2018
7:30 AM ET
Press Release

Abstract Outlining Pre-Hospital Stroke Study with Diffusion Pharmaceuticals’ TSC To Be Presented at the International Stroke Conference

1/24/2018

CHARLOTTESVILLE, Va., Jan. 24, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc.(Nasdaq:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on improving patien...

 Continue Reading
Displaying 1 to 7 (of 95 releases)